Penn Medicine Abramson Cancer Center

 

Update on Patient Care Treatment Strategies in Leukemia
10:07

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 Updates on MDS Treatment: Luspatercept Reduces Anemia, Lenalidomide and Epoetin Alfa Leads to Durable Responses, Experience with HMAs, ASTX727 as Alternative to IV Decitabine

FEATURING Shannon McCurdy
  • 75 views
  • February 24, 2020
16:32

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 Update on Novel Therapies for Higher Risk MDS: IDH Inhibitors, Azacitidine Combinations (Ven+Aza & Magrolimab+Aza), Targeting TP53 Mutations

FEATURING Shannon McCurdy
  • 12 views
  • February 24, 2020
22:27

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 MPN Review: Anti-thrombotic Therapy & Ropeginterferon in PV; Second Cancer in Ph- MPN; Fedratinib and Luspatercept in MF

FEATURING Daria V. Babushok
  • 12 views
  • February 24, 2020
09:40

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 Update on New Developments in CML: Asciminib Effective in Pts with all ATP Pocket Mutations & Predicting Success of TFR

FEATURING Daria V. Babushok
  • 11 views
  • February 24, 2020
18:13

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 Update on AML: Frontline Regimen Driven by Genetic Subgroups Both For Prognosis and Therapy Choice

FEATURING Alexander Perl
  • 12 views
  • February 24, 2020
10:12

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 AML Update: Maintenance Therapy is Likely to Become Standard - Update on Trials with Oral Azacitidine & Gilteritinib

FEATURING Alexander Perl
  • 415 views
  • February 24, 2020
  • 1
05:38

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

ASH 2019 Updates for ALL: C10403 Induction Chemotherapy & Optimizing CART-19 for Adults

FEATURING Alexander Perl
  • 14 views
  • February 24, 2020